The pharmaceutical composition for treating or preventing for inflammation disease using Tryptophanase-negative bacteria and bacteria inducing Interferon gamma and method using thereof
KR20190089826A
The pharmaceutical composition for treating or preventing for inflammation disease using Tryptophanase-negative bacteria and bacteria inducing Interferon gamma and method using thereof
KR102044153B1
the noble Bacillus licheniformis strain and process of manufacturing of immune exopolysaccharide thereof
KR20190111584A
Lactobacillus fermentum having anti-inflammatory effects on intestinal epithelial cells, and compositions for treating and preventing inflammatory bowel disease comprising thereof
KR20190111582A
Lactobacillus paracasei having anti-inflammatory effects on intestinal epithelial cells, and compositions for treating and preventing inflammatory bowel disease comprising thereof
KR20190004586A
The method of stool suggestion for FMT
KR20180105381A
The pharmaceutical composition for treating or preventing for inflammation disease using Tryptophanase-negative bacteria and bacteria inducing Interferon gamma and method using thereof
KR20180105380A
Mucoadhesive devices for the release of probiotics and for the maintenance of their enzyme activities
KR20170085930A
Method for providing health care information using the Gut Microbiota Analysis
